NEPTUNE: Phase III Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC.
暂无分享，去创建一个
Ying Cheng | K. Syrigos | N. Rizvi | P. Schmid | Y. Summers | N. Yamamoto | I. Vynnychenko | G. de Castro | R. Raja | H. Mann | Jill Walker | M. Erman | V. Moiseyenko | A. Zer | U. Scheuring | C. Timcheva | V. Chand | T. Mok | S. Lee | M. Bryl | Claudio Martin | K. Naicker